Neoplasia/BPH

	Congenital nephrotic syndrome in a newborn with glycogen storage disease and Wilms tumor 1 (WT1) mutation. CEN Case Rep Annicchiarico Petruzzelli L, De Marco O, Improda N, Giannattasio P, Luongo I, Carucci M, Brunetti B, Serio V, Minale B, Malgieri G. PMID: 41495530 [PubMed - indexed for MEDLINE]
	Radiographic Progression-Free Survival as a Surrogate Endpoint for Overall Survival in First-Line ARPi NaÃ¯ve Metastatic Castration-Resistant Prostate Cancer. Oncologist Castro E, Paganelli S, Wang D, Haltner A, Niyazov A, Chang J, Samjoo IA, Barata PC. PMID: 41495009 [PubMed - as supplied by publisher]
	Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 Trial. Eur Urol Ghadjar P, Hayoz S, Zwahlen DR, Hölscher T, Arnold W, Polat B, Hildebrandt G, Hoffmann E, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Riesterer O, Beck M, Thalmann GN, Aebersold DM, Swiss Group for Clinical Cancer Research (SAKK). PMID: 41494929 [PubMed - as supplied by publisher]
	Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103. Brachytherapy King M, Miri, Sayan M, Galbreath R, Fiano R, Wallner K, Orio P. PMID: 41494910 [PubMed - as supplied by publisher]
	YY1 in prostate cancer: multidimensional oncogenicmechanisms and emerging therapeutic vulnerabilities. J Mol Histol Liu Q, Liang Z, Li L, Wen R, Mo L, Liu Y, Wang X. PMID: 41495564 [PubMed - in process]
	Retraction Note: The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study. Sci Rep Rahimnia R, Akbari MR, Yasseri AF, Taheri D, Mirzaei A, Ghajar HA, Farashah PD, Baghdadabad LZ, Aghamir SMK. PMID: 41495158 [PubMed - in process]
	Unraveling the microbial landscape in prostate cancer: pathogenesis to therapy. NPJ Biofilms Microbiomes Du X, Wu J, Xia S, Zheng H, Zhang B. PMID: 41495053 [PubMed - as supplied by publisher]
	Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next. NPJ Vaccines Rajabi R, Vafaei S, Afrashteh F, Ghods R, Madjd Z. PMID: 41495048 [PubMed - as supplied by publisher]
	Amino Acid Metabolic Reprogramming in Clear Cell Renal Cell Carcinoma: Pathogenic Mechanisms and Therapeutic Targeting. Cancer Lett Xie J, Ni F, Shao J, Zhang D, Guo T, Wang X. PMID: 41494569 [PubMed - as supplied by publisher]
	Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients. Clin Invest Med Zheng D. PMID: 41493767 [PubMed - indexed for MEDLINE]
	Persistent lymph node uptake on [18Â F]-FDG PET-CT after neoadjuvant chemotherapy: a major predictive factor of disease-free survival in MIBC. World J Urol Pattou M, Robert G, Gouhizoun O, Guéna F, Khaddad A, Mebroukine S, Margue G, Gross-Goupil M, Lefort F, Morgat C, Bernhard JC, Bladou F, Klein C. PMID: 41493567 [PubMed - indexed for MEDLINE]
	A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol Hudson A, Jayaram A, Garmezy B, Zorko NA, Zarrabi KK, Mathews L, Rupnow B, Li M, Ghosh D, Urtishak K, Francis P, Wang SC, Attiyeh E, de Bono J. PMID: 41493473 [PubMed - indexed for MEDLINE]
	Comments on "Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial". Int J Cancer Dai J, Zhou X. PMID: 41493148 [PubMed - as supplied by publisher]
	Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer. J Comp Eff Res Shore N, Morgans AK, Paracha N, Thom H, Keeney E, Orishaba P, Phillippo D, Aceituno D, Wallis CJ, Gallagher E, Boegemann M. PMID: 41492975 [PubMed - as supplied by publisher]
	Epidemiological trends and future projections of bladder and kidney cancer burden in China, 1990-2041: an ecological study. Chin Clin Oncol Yuan J, Yu S, Zheng J. PMID: 41492875 [PubMed - indexed for MEDLINE]
	Gleason score discrepancies between prostate biopsy and radical prostatectomy in prostate cancer patients: a retrospective single-center analysis. Chin Clin Oncol Chen Y, Luo J, Dong Q, Zhou T, Wang C, Xiao J. PMID: 41492874 [PubMed - indexed for MEDLINE]
	Analysis of Urinary Continence, Complications, and Urodynamic Characteristics Following Orthotopic Ileocaecal Neobladder Reconstruction: A Preliminary Study on Safety and Feasibility. Arch Esp Urol Fu Q, Yan F, Sun Z, Yao Z, Zhang G. PMID: 41492682 [PubMed - indexed for MEDLINE]
	Value Analysis of Operating Room Care Protocol Based on Enhanced Recovery after Surgery (ERAS) Concept in Patients with Prostate Cancer Undergoing Laparoscopic Radical Prostatectomy: A Retrospective Study. Arch Esp Urol Zhang L, Gu C. PMID: 41492681 [PubMed - indexed for MEDLINE]
	Study on Symptom Management Theory-Based Nursing Treatment Model for Patients Undergoing Radical Prostatectomy: A Single-Center, Retrospective Experience. Arch Esp Urol Xu H, Zhong G, He R. PMID: 41492680 [PubMed - indexed for MEDLINE]
	Extraperitoneal Laparoscopic Surgery versus Transurethral Resection for Benign Prostatic Hyperplasia: A Retrospective Comparative Analysis of Perioperative Outcomes and Functional Recovery. Arch Esp Urol Ying X, Gao K, Xu Z, Zhang H, Shen C, Ren Y, Luo Z, Wu G. PMID: 41492677 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 184455

Page 1 of 9223



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy